Differences of Plasma Levels of Tryptophan, Serotonin, 5-Hydroxyindole Acetic Acid, and Kynurenine between Healthy People and Patients of Major Monopolar Depression at Various Age and Gender — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Differences of Plasma Levels of Tryptophan, Serotonin, 5-Hydroxyindole Acetic Acid, and Kynurenine between Healthy People and Patients of Major Monopolar Depression at Various Age and Gender
Department of Psychiatry, Showa University Northern Yokohama Hospital, Yokohama, Japan
,
Global Application Development Center, Shimadzu Corporation, Tokyo, Japan
,
International Projects on Food and Health (NPO), Tokyo, Japan
,
Department of Psychiatry, School of Medicine, Showa University, Tokyo, Japan
1 Department of Psychiatry, Showa University Northern Yokohama Hospital, Yokohama, Japan
2 Global Application Development Center, Shimadzu Corporation, Tokyo, Japan
3 International Projects on Food and Health (NPO), Tokyo, Japan
4 Department of Psychiatry, School of Medicine, Showa University, Tokyo, Japan
Background: It is not well analyzed whether there are differences in plasma levels of tryptophan (TRP) metabolites between healthy control people (HC) and patients of major monopolar depression (MMD). Methods: Ultra high-speed liquid chromatography/mass spectrometry has been used for the simultaneous determination of plasma levels of tryptophan metabolites in depressive patients. Results: There are no significant differences between plasma levels of TRP between HC and MMD. Plasma levels of TRP of HC are higher in young men, young women, old men, and old women in this order. Serotonin (5-HT) levels are higher in MMD than HC. Plasma levels of 5-HIAA of HC are also higher than those of patients of MMD. Plasma levels of kynurenine (KYN) of healthy old men and old women are higher than those of young men and old women. Plasma levels of KYN are higher in old women and young men of MMD than those of HC. Conclusion: Plasma levels of 5-HT are higher in patients of MMD than those of HC, which may suggest that use of drugs inhibiting the 5-HT transportation may increase plasma levels of 5-HT in MMD.
Cahn, C. (2006) Roland Kuhn, 1912-2005. Neuropsychopharmacology, 31, 1096. https://doi.org/10.1038/sj.npp.1301026
Ross, S.B. and Renyi, A.L. (1969) Inhibition of the Uptake of Tritiated 5-Hydroxy-tryptamine in Brain Tissue. European Journal of Pharmacology, 7, 270-277. https://doi.org/10.1016/0014-2999(69)90091-0
Drugs.com. http://www.drugs.com/top 200.html
Ioannidis, J.P. (2008) Effectiveness of Antidepressants: An Evidence Myth Constructed from a Thousand Randomized Trials? Philosophy, Ethics, and Humanities in Medicine, 3, 14. https://doi.org/10.1186/1747-5341-3-14
Kirsch, I., Deacon, B.J., Huedo-Medina, T.B., Scoboria, A., Moore, T.J. and Johnson, B.T. (2008) Initial Severity and Antidepressant Benefit: Meta-Analysis of Data Submitted to the Food and Drug Administration. PLOS Medicine, 5, e45. https://doi.org/10.1371/journal.pmed.0050045
Cipriani, A., Furukawa, T.A., Salanti, G., Chaimani, A., Atkinson, L.Z., Ogawa, Y., Leucht, S., Ruhe, H.G., Turner, E.H., Higgins, J.P.T., Egger, M., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K., Tajika, A., Ioannidis, J.P.A. and Geddes, J.R. (2018) Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults with Major Depressive Disorder: A Systematic Review and Network Meta-Analysis. The Lancet, 391, 1357-1366. https://doi.org/10.1016/S0140-6736(17)32802-7
Matsuoka, K., Kato, K., Takao, T., Ogawa, M., Ishii, Y., Shimizu, F., Masuda, J. and Takada, A. (2016) Concentrations of Various Tryptophan Metabolites Increase in Patients of Diabetes Mellitus Compared to Healthy Aged Male Adults. Diabetology International, 8, 69-72. https://doi.org/10.1007/s13340-016-0282-y
Takada, A., Shimizu, F. and Masuda, J. (2018) Measurement of Plasma Tryptophan Metabolites: Clinical and Experimental Application for Depression and Stress States Assessment. In: Dragoi, C.M. and Nicolae, A.C., Eds., Melatonin—Molecular Biology, Clinical and Pharmaceutical Approaches, IntechOpen, London, 143-160. https://doi.org/10.5772/intechopen.78560
Shimizu, F., Ishii, Y., Ogawa, M., Takao, T., Matsuoka, K., Kato, K. and Takada, A. (2018) Plasma Levels of Tryptophan Metabolites in Healthy Young and Old Men and Women, and Patients of Type 2 Diabetes Mellitus (T2DM). Obesity: Open Access, 4, 1-9. https://doi.org/10.16966/2380-5528.138
Takada, A., Shimizu, F. and Masuda, J. (2019) Plasma Levels of Tryptophan Metabolites in Patients of Type 2 Diabetes Mellitus. In: Watson, R. and Preedy, V., Eds., Bioactive Food as Dietary Interventions for Diabetes, 2nd Edition, Academic Press, Cambridge, 265-276. https://doi.org/10.1016/B978-0-12-813822-9.00017-5
Tomioka, H., Masuda, J., Takada, A. and Iwanami, A. (2020) Comparison Age and Gender Differences of Tryptophan Metabolites in Patients of Major Monopolar and Bipolar Depression. Food and Nutrition Science, 11, 172-185. https://doi.org/10.4236/fns.2020.113013
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-5). APA, Washington DC. https://doi.org/10.1176/appi.books.9780890425596
Guy, W. (1976) Clinical Global Impressions ECDEU Assessment Manual for Psychopharmacology, Revised (DHEW Publ. No. ADM 76-338). National Institute of Mental Health, Rockville, 218-222. https://doi.org/10.1037/e591322011-001
Zung, W.W.K. (1965) A Self-Rating Depression Scale. Archives of General Psychiatry, 12, 63-70. https://doi.org/10.1001/archpsyc.1965.01720310065008
Hamilton, M. (1960) A Rating Scale for Depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56-62. https://doi.org/10.1136/jnnp.23.1.56
Maes, M. (1993) A Review on the Acute Phase Response in Major Depression. Reviews in the Neurosciences, 4, 407-416. https://doi.org/10.1515/REVNEURO.1993.4.4.407
Oxenkrug, G.F. (2010) Tryptophan Kynurenine Metabolism as a Common Mediator of Genetic and Environmental Impacts in Major Depressive Disorder: The Serotonin Hypothesis Revisited 40 Years Later. Israel Journal of Psychiatry and Related Sciences, 47, 56-63.
Réus, G.Z., Jansen, K., Titus, S., Carvalho, A.F., Gabbay, V. and Quevedo, J. (2015) Kynurenine Pathway Dysfunction in the Pathophysiology and Treatment of Depression: Evidences from Animal and Human Studies. Journal of Psychiatric Research, 68, 316-328. https://doi.org/10.1016/j.jpsychires.2015.05.007
Mann, J.J., Malone, K.M., Sweeney, J.A., Brown, R.P., Linnoila, M., Stanley, B. and Stanley, M. (1996) Attempted Suicide Characteristics and Cerebrospinal Fluid Amine Metabolites in Depressed Inpatients. Neuropsychopharmacology, 15, 576-586. https://doi.org/10.1016/S0893-133X(96)00102-9
Mann, J.J. and Arango, V. (1992) Integration of Neurobiology and Psychopathology in a Unified Model of Suicidal Behavior. Journal of Clinical Psychopharmacology, 12, 2S-7S. https://doi.org/10.1097/00004714-199204001-00001
Perroud, N., Neidhart, E., Petit, B., Vessaz, M., Laforge, T., Relecom, C., La Harpe, R., Malafosse, A. and Guipponi, M. (2010) Simultaneous Analysis of Serotonin Transporter, Tryptophan Hydroxylase 1 and 2 Gene Expression in the Ventral Prefrontal Cortex of Suicide Victims. American Journal of Medical Genetics Part B, Neuropsychiatric Genetics, 153, 909-918. https://doi.org/10.1002/ajmg.b.31059
Bach-Mizrachi, H., Underwood, M.D., Kassir, S.A., Bakalian, M.J., Sibille, E., Tamir, H., Mann, J.J. and Arango, V. (2006) Neuronal Tryptophan Hydroxylase mRNA Expression in the Human Dorsal and Median Raphe Nuclei: Major Depression and Suicide. Neuropsychopharmacology, 31, 814-824. https://doi.org/10.1038/sj.npp.1300897
Boldrini, M., Underwood, M.D., Mann, J.J. and Arango, V. (2005) More Tryptophan Hydroxylase in the Brainstem Dorsal Raphe Nucleus in Depressed Suicides. Brain Research, 1041, 19-28. https://doi.org/10.1016/j.brainres.2005.01.083
Sarriaz, M.J., Cabre, P., Martinez, E. and Artigas, F. (1990) Relationship between Serotonergic Measures in Bloos and Cerebrospinal Fluid Simultaneously Obtained in Humans. Journal of Neurochemistry, 54, 783-786. https://doi.org/10.1111/j.1471-4159.1990.tb02319.x
Owen, F., Chambers, D.R., Cooper, S.J., Crow, T.J., Johnson, J.A., Lofthouse, R. and Poulter, M. (1986) Serotonergic Mechanisms in Brains of Suicide Victims. Brain Research, 362, 185-188. https://doi.org/10.1016/0006-8993(86)91415-0
Arango, V., Underwood, M.D., Gubbi, A.V. and Mann, J.J. (1995) Localized Alterations in Pre- and Postsynaptic Serotonin Biding Sites in the Ventrolateral Prefrontal Cortex of Suicide Victims. Brain Research, 688, 121-133. https://doi.org/10.1016/0006-8993(95)00523-S